Medical Advisory Board

Aortech International PLC
15 August 2006





                                                                  15 August 2006

                           AorTech International plc
                          ('AorTech' or 'the Company')

           AorTech International plc appoints Medical Advisory Board
          Key opinion leaders in breast plastic surgery come on board

London, UK - AorTech International plc (AIM: AOR), the medical device
development and biomaterials intellectual property and licensing company, today
announces the creation of a Medical Advisory Board, with the appointment of
esteemed plastic surgeons, V. Leroy Young, M.D., and Mark L Jewell, M.D. Between
them, they bring eighty years' combined experience in plastic surgery. The
Medical Advisory Board will play a key role in the development and promotion of
AorTech's unique and highly versatile Elast-EonTM product, in a range of
surgical applications.

Leroy Young (aged 60) is currently Plastic Surgeon and Partner at Body Aesthetic
Plastic Surgery & Skincare Centre, Chief of Surgical Services, Barnes-Jewish
West County Hospital and a Consultant at the Breast Implant Research Group at
Washington University, St Louis, Missouri. Over a period of 13 years he played a
key leadership role in the American Society for Aesthetic Plastic Surgeons
(ASAPS), where he served on the Board of Directors and held a number of
committee positions, including leadership in strategic planning, finance and
investment and patient safety issues. Dr Young is on the Breast Implant Task
Force, and a key opinion leader and publisher of articles (over 170) in this
field.

Mark Jewell (aged 58) is an Assistant Clinical Professor of Plastic Surgery at
Oregon Health Science University in Portland, Oregon and has practiced plastic
surgery in Eugene, Oregon for the last 27 years. He holds several leadership
positions at the ASAPS and is currently Immediate Past President. He is also
Co-Chair of the Breast Implant Task Force and Group Co-Chair of the Breast
Implant Work Group for the ASAPS and ASPS (American Society of Plastic
Surgeons). Mark also brings valuable experience in general and breast surgery to
the Medical Advisory Board. He has extensive experience of technological
innovations in plastic surgery in plastic surgery and has authored 40
peer-reviewed articles and books.

With these two appointments, AorTech will have access to regulatory, strategic
and practical advice, as well as a high level of counsel from these key opinion
leaders.

Frank Maguire, Chief Executive of AorTech, said:

'The appointment of Drs. Jewell and Young, who are both highly regarded surgeons
and researchers, adds great credence to AorTech's proposition. The aim is that
they will guide, advise and challenge the current AorTech team and provide a
valuable sounding board for the Group.

'A key strand to our development programme over the coming months will be to
pursue proof of concept for the minimally invasive breast implant, at which time
we will seek a partner to take this product through clinical trials and
ultimately to commercial use. With the Medical Advisory Board in place, we
believe we are well positioned to pursue our goals and take full advantages of
the opportunity that we believe will emerge with the continued evolution and
regulatory advances within this market place.'

                                     -Ends-
Enquiries:

AorTech International plc                        Tel: [phone]
Frank Maguire, Chief Executive Officer

Hogarth Partnership Limited                      Tel: [phone]
Melanie Toyne-Sewell / Andrew Jaques/
Sarah Richardson




                      This information is provided by RNS
            The company news service from the London Stock Exchange